Possibilities of using the natural nootropic agent “Memo-Vit” in the prevention and complex therapy of various types of dementia
- Authors: Elistratov D.G.1
-
Affiliations:
- Parapharm LLC
- Issue: Vol 26, No 4 (2024)
- Pages: 18-23
- Section: Prevention issues
- URL: https://journals.eco-vector.com/0025-8342/article/view/633537
- DOI: https://doi.org/10.29296/25879979-2024-04-03
- ID: 633537
Cite item
Open Access
Access granted
Abstract
The article deals with the problem of increasing cases of dementia on a global scale. The latest statistical data and forecasts on the spread of the disease are given. The main reasons for the emergence and progression of pathology are highlighted. Modern means of its prevention and treatment are characterized. The composition of the nootropic drug of natural origin “Memo-Vit” is analyzed, the prospects of using this drug in the prevention and complex therapy of dementia are evaluated.
Full Text
About the authors
Dmitry G. Elistratov
Parapharm LLC
Author for correspondence.
Email: dge117@mail.ru
ORCID iD: 0000-0001-7809-480X
General Director
Russian Federation, PenzaReferences
- World Alzheimer Report 2009. Alzheimer’s Disease International URL: http://www.alz.org/national/documents/report_summary_2009worldalzheimerreport.pdf (дата обращения: 09.08.2023).
- Tanshina O.V. Patients with dementia. Meditsinskaya sestra (The Nurse). 2015; 4: 35–38. (in Russ.).
- Sidorova I., Shirokova I. Dementia: a problem and its solutions. Remedium. 2014; 11:14–20. (in Russ.).
- Gorelik S.G., Orobtsova M.V., Avdeeva I.V. et al. Dementia. Meditsinskaya sestra (The Nurse). 2018; 20 (5): 16–19. (in Russ.)]. https://doi.org/10.29296/25879979-2018-05-05 [
- Koldova T., Verbitskaya O., Baranova G. et al. Cognitive disorders in comorbid patients with chronic cerebral ischemia and hypothyroidism. Vrach. 2019; 30 (11): 75–79 (in Russ.). https://doi.org/10.29296/25877305-2019-11-18
- Cherdak M.A., Uspenskaya O.V. Vascular dementia. Nevrologiya, nejropsihiatriya, psihosomatika. 2010; 1: 30–36. (in Russ.).
- Grigolashvili M.A., Beisembaeva M.B., Shatokhina T.P. et al. Risk of dementia in Parkinson’s disease. Literature review. Universum: medicina i farmakologiya. 2021; 2 (75): 13–18. (in Russ.). doi: 10.32743/UniMed.2021.75.2.13-18
- Strukov V., Elistratov D., Kislov A. et al. Osteoporosis in geriatric practice. Vrach. 2018; 29 (6): 26–30 (in Russ.).
- Petrova E.V., Kalistratov V.B., Poluboyarinov P.A. et al. Nootropic and neuroprotective effects of the Memo-Vit natural biocomplex. Sovremennye problemy fitoterapii i travnichestva: Proceedings of the 5th International Congress of Phytotherapists and Herbalists. 2019; 309–315. (in Russ.).
- Sabitov A.M., Magafurova F.F., Khusnutdinov V.V. On new directions of buckwheat breeding in the Bashkir Research Institute of Agriculture. Dostizheniya nauki i tekhniki APK. 2010; 3: 20–22. (in Russ.).
- Wang W., Wu Q. H., Sui Y. Rutin protects endothelial dysfunction by disturbing Nox4 and ROS-sensitive NLRP3 inflammasome. Biomed Pharmacother. 2017; 86: 32–40.
- Aghababyan Sh. M. Forage plants of hayfields and pastures of the USSR: in 3 vols. Moscow; Leningrad: Selkhozgiz. 1951. 512. (in Russ.).
- Strukov V., Elistratov D., Balykova L. et al. Effect of Osteomed Forte on the hormonal status and course of osteoporosis in postmenopausal women with androgen deficiency. Vrach. 2015; 3:28–32. (in Russ.).
- Strukov V.I., Katyushina Yu.G., Eremina N.V. et al. Discovery in the treatment of presenile and senile osteoporosis. Mezhdunarodnyj zhurnal prikladnyh i fundamental’nyh issledovanij. 2013; 9:122–124. (in Russ.).
- Petrova E., Kalistratov V., Poluboyarinov P. et al. The drug Femo-Klim used for menopause is the best non-hormonal solution to hormonal problems. Vrach. 2019; 30 (1): 46–49. (in Russ.).
Supplementary files
